MIR196A2 rs11614913: What Your Genotype Means
The rs11614913 variant is a common genetic polymorphism located within the MIR196A2 gene. It has been studied for its potential role in altering microRNA function and its statistical association with susceptibility to various epithelial and solid tumors.
What each genotype means
Baseline risk profile
This genotype represents the common form of the MIR196A2 variant. Research into this polymorphism is inconclusive, with some studies suggesting associations with altered cancer susceptibility in specific populations, though these findings are not consistent across all groups.
This is a common genotype found globally, though its exact frequency varies significantly by ancestry.
Variable risk profile
Carrying one copy of the T allele may influence the efficiency of miR-196a-3p in binding to target mRNA. While some meta-analyses suggest a correlation with differential cancer risk in Asian and African populations, the evidence remains limited and inconsistent across different types of cancer.
This heterozygous genotype is frequently observed in most populations, reflecting the high prevalence of both the C and T alleles.
Variable risk profile
This genotype results in the presence of two copies of the T allele, which may alter microRNA function compared to the C allele. Statistical associations with cancer risk have been reported in various studies, but these results are often ancestry-specific and remain a subject of ongoing scientific debate.
This genotype is common, particularly in populations where the T allele frequency is elevated, such as in many East Asian cohorts.
Understanding the rs11614913 Variant
The rs11614913 variant is a single nucleotide polymorphism (SNP) situated within the MIR196A2 gene. Specifically, this variant is located in the mature miR-196a-3p region, a small, non-coding RNA molecule. Because this SNP sits within a functional region of the microRNA, researchers hypothesize that it may influence the maturation process or the binding efficiency of the microRNA to its target messenger RNA (mRNA) molecules. By altering how these microRNAs interact with their targets, the variant may indirectly affect the expression of various genes involved in cellular growth and regulation. While the biological mechanism is a subject of ongoing investigation, the primary interest in this variant stems from its potential to modulate gene expression pathways that are often dysregulated in complex diseases.
The Role of MIR196A2
The MIR196A2 gene encodes a precursor microRNA that is processed into mature miR-196a. MicroRNAs are essential regulators of gene expression; they typically bind to specific sequences on target mRNAs, leading to the degradation of the mRNA or the inhibition of protein translation. In the context of human health, miR-196a is known to play a role in developmental processes and cellular homeostasis. When the function of this microRNA is altered—potentially by a genetic variant like rs11614913—it may disrupt the delicate balance of gene expression within a cell. This disruption is why scientists have focused on this gene in studies related to oncology and cardiovascular health, as the pathways regulated by miR-196a are frequently involved in cell proliferation, apoptosis, and tissue remodeling.
Research Associations and Evidence Strength
Research into rs11614913 has primarily focused on its statistical association with cancer risk, including lung, gastric, esophageal, and head and neck cancers. Numerous studies, including meta-analyses, have suggested that this variant may correlate with differential susceptibility to these conditions, particularly in Asian populations. Additionally, some recent research has explored potential links between this variant and cardiovascular outcomes, such as myocardial infarction. However, it is important to note that the evidence strength for these associations is currently considered limited. Many findings are based on observational studies that show mixed results across different ethnic groups and disease subtypes. Because these associations are statistical in nature and often show small effect sizes, they do not establish a direct cause-and-effect relationship. Further large-scale, multi-ethnic studies are required to confirm these preliminary observations.
Interpreting Your Genetic Information
If you have received information about your rs11614913 genotype, it is essential to view it within the context of your overall health and lifestyle. This variant is a common polymorphism, meaning it is found in a significant portion of the general population and is not a definitive indicator of disease. Genetic associations with complex traits like cancer or heart disease are influenced by a vast array of factors, including other genetic variants, environmental exposures, and personal health history. You cannot use this information to diagnose yourself or predict future health outcomes with certainty. If you are concerned about your risk for specific conditions, the most effective approach is to consult with a healthcare professional or a genetic counselor. They can help you interpret your results in light of your clinical history and provide guidance on appropriate screening or preventative measures.
How common is this variant?
The rs11614913 variant is common, with a minor allele frequency of approximately 0.35–0.40 in European populations and 0.45–0.50 in East Asian ancestries.
Frequently asked questions
Is rs11614913 a diagnostic test for cancer?
No, rs11614913 is not a diagnostic test. It is a common genetic variant associated with statistical differences in risk for certain conditions, but it cannot predict whether an individual will develop a disease.
What should I do if I have the 'risk' genotype?
Having a specific genotype does not mean you will develop a disease. You should focus on established health practices, such as regular screenings and healthy lifestyle choices, and discuss any specific concerns with your doctor.
Why do results for this variant differ between studies?
Genetic associations can vary due to differences in study design, the ethnic background of the participants, and the influence of other environmental or genetic factors that interact with the variant.
Is this variant related to medication response?
There is currently no widely accepted clinical evidence linking rs11614913 to specific medication responses. Always consult your pharmacist or clinician before making changes to your prescribed treatments.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11614913?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29